Research
GLP-1 weight-loss drugs linked to inadequate intake of key nutrients in some people
The Brief
- A small exploratory study links GLP-1 weight-loss drugs, such as Wegovy and Mounjaro, to inadequate intakes of key nutrients and energy in some people.
- The study was published in the journal BMJ Nutrition Prevention & Health.
- The findings come from a small exploratory study, so they show an association in some users rather than a established cause or a population-wide effect.
Why it matters
Drugs that suppress appetite may leave some users short of essential nutrients and energy, which matters for anyone prescribing or monitoring these treatments.
Who’s affected
- clinicians and dietitians who monitor patients taking GLP-1 weight-loss drugs
- people taking or considering GLP-1 weight-loss drugs
- #glp-1
- #nutrition
- #weight-loss drugs
- #diet
- #nutrient intake
Drugs taken to suppress appetite, such as Wegovy and Mounjaro, are associated with inadequate intakes of key nutrients and energy in some people, finds a small exploratory study published in the journal BMJ Nutrition Prevention & Health.